...
首页> 外文期刊>Russian Chemical Bulletin >Synthesis of covalent conjugates of hexaarabinofuranoside with proteins and their testing as antigens for serodiagnosis of tuberculosis
【24h】

Synthesis of covalent conjugates of hexaarabinofuranoside with proteins and their testing as antigens for serodiagnosis of tuberculosis

机译:六呋喃呋喃糖苷共价结合物与蛋白质的合成及其作为抗原的结核分枝杆菌血清学检测

获取原文
获取原文并翻译 | 示例

摘要

Specificity and sensitivity are crucial in diagnosis of tuberculosis. An insufficiently sensitive method will "miss" too many persons really sick with active tuberculosis. If the method is insufficiently specific, its use will give many false positive results among healthy people or among non-tubercular patients (the latter fact is not too critical for mass screening of population, because the primary diagnosis is always checked by alternative methods). Enzyme-linked immunosorbent analysis (ELISA), immunochro-matography (IC), and dot-blotting technique using one or several recombinant protein antigens of Mycobacterium tuberculosis were developed in the recent time for serodiagnosis of tuberculosis. In particular, an array of recombinant antigens (38-, 63-, 64-, 14-, and 59-kDa) is successfully used in commercial serological assays TB-DOT (Upper Bio-tech, China, http://www.poct.cn) and TB-Check-1 (VEDA.LAB, France, http://www.vedalab.com); the declared assay specificity reaches 99.42%, and the sensitivity is 98.52% (see Ref. 1). However, it was found when using these tests that this level of sensitivity is reached only for certain human populations, which can be associated with national and ethnic peculiarities of the humoral immune response to tuberculosis.For example, 11 recombinant proteins of M. tuberculosis have earlier been obtained and used as antigens for the analysis of 320 sera of sick and healthy peoples from the central region of Russia. None of them provided the sensitivity higher than 55%, and various combinations of antigens increased this parameter by at most 7 %.
机译:特异性和敏感性对结核病的诊断至关重要。敏感性不足的方法将使很多真正患有活动性结核病的人“错过”。如果该方法的特异性不足,则在健康人群或非结核性患者中使用该方法会产生许多假阳性结果(后一种事实对于人群筛查并不是太关键,因为主要诊断方法始终是通过其他方法进行检查)。近年来,开发了一种使用结核分枝杆菌的一种或几种重组蛋白抗原的酶联免疫吸附分析(ELISA),免疫层析技术(IC)和斑点印迹技术,用于结核病的血清学诊断。特别地,一系列重组抗原(38-,63-,64-,14-和59-kDa)已成功用于商业血清学测定TB-DOT(Upper Bio-tech,中国,http://www.upper-bio-tech.com)。 poct.cn)和TB-Check-1(法国VEDA.LAB,http://www.vedalab.com);宣称的测定特异性达到99.42%,灵敏度为98.52%(参见参考文献1)。但是,使用这些测试发现仅某些人群达到了这种水平的敏感性,这可能与针对结核病的体液免疫反应的国家和种族特征有关。例如,结核分枝杆菌有11种重组蛋白较早地获得并用作抗原,用于分析俄罗斯中部地区320名患病和健康人群的血清。它们都没有提供高于55%的灵敏度,并且抗原的各种组合最多可将这一参数提高7%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号